These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 39169393)
1. A lot testing protocol for quality assurance of fentanyl test strips for harm reduction applications. Fernando H; Amate A; Hayes KL; Whitehead HD; Desnoyers C; Uzobuife E; Denchfield MS; Whitelatch B; Lieberman M Harm Reduct J; 2024 Aug; 21(1):152. PubMed ID: 39169393 [TBL] [Abstract][Full Text] [Related]
2. An urgent need for community lot testing of lateral flow fentanyl test strips marketed for harm reduction in Northern America. Lieberman M; Badea A; Desnoyers C; Hayes K; Park JN Harm Reduct J; 2024 Jun; 21(1):115. PubMed ID: 38877522 [TBL] [Abstract][Full Text] [Related]
3. Evaluating fentanyl test strips as a harm reduction strategy in rural and urban counties: study protocol for a randomized controlled trial. Short Mejia A; Smith GA; Fernandez SA; Freisthler B; Grella C; Michaels NL Trials; 2024 Sep; 25(1):587. PubMed ID: 39232778 [TBL] [Abstract][Full Text] [Related]
4. Assessment of two brands of fentanyl test strips with 251 synthetic opioids reveals "blind spots" in detection capabilities. Hayes KL; Lieberman M Harm Reduct J; 2023 Dec; 20(1):175. PubMed ID: 38057832 [TBL] [Abstract][Full Text] [Related]
5. Use of rapid fentanyl test strips among young adults who use drugs. Krieger MS; Goedel WC; Buxton JA; Lysyshyn M; Bernstein E; Sherman SG; Rich JD; Hadland SE; Green TC; Marshall BDL Int J Drug Policy; 2018 Nov; 61():52-58. PubMed ID: 30344005 [TBL] [Abstract][Full Text] [Related]
6. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Lockwood TE; Vervoordt A; Lieberman M Harm Reduct J; 2021 Mar; 18(1):30. PubMed ID: 33750405 [TBL] [Abstract][Full Text] [Related]
7. Fentanyl Test Strips for Harm Reduction: A Scoping Review. Kutscher E; Barber Grossi M; LaPolla F; Lee JD J Addict Med; 2024 Jul-Aug 01; 18(4):373-380. PubMed ID: 38829042 [TBL] [Abstract][Full Text] [Related]
8. Testing the test strips: laboratory performance of fentanyl test strips. Halifax JC; Lim L; Ciccarone D; Lynch KL Harm Reduct J; 2024 Jan; 21(1):14. PubMed ID: 38238757 [TBL] [Abstract][Full Text] [Related]
9. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples. Park JN; Sherman SG; Sigmund V; Breaud A; Martin K; Clarke WA Drug Alcohol Depend; 2022 Nov; 240():109610. PubMed ID: 36115223 [TBL] [Abstract][Full Text] [Related]
10. Advances in fentanyl testing. Uljon S Adv Clin Chem; 2023; 116():1-30. PubMed ID: 37852717 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a lateral flow immunoassay for the detection of the synthetic opioid fentanyl. Angelini DJ; Biggs TD; Maughan MN; Feasel MG; Sisco E; Sekowski JW Forensic Sci Int; 2019 Jul; 300():75-81. PubMed ID: 31078080 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada. Karamouzian M; Dohoo C; Forsting S; McNeil R; Kerr T; Lysyshyn M Harm Reduct J; 2018 Sep; 15(1):46. PubMed ID: 30200991 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the sensitivity, stability, and cross-reactivity of commercial fentanyl immunoassay test strips. Rodriguez-Cruz SE J Forensic Sci; 2023 Sep; 68(5):1555-1569. PubMed ID: 37420315 [TBL] [Abstract][Full Text] [Related]
14. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Goldman JE; Waye KM; Periera KA; Krieger MS; Yedinak JL; Marshall BDL Harm Reduct J; 2019 Jan; 16(1):3. PubMed ID: 30621699 [TBL] [Abstract][Full Text] [Related]
15. Drug checking services at music festivals and events in a Canadian setting. McCrae K; Tobias S; Tupper K; Arredondo J; Henry B; Mema S; Wood E; Ti L Drug Alcohol Depend; 2019 Dec; 205():107589. PubMed ID: 31605958 [TBL] [Abstract][Full Text] [Related]
16. Understanding sensitivity and cross-reactivity of xylazine lateral flow immunoassay test strips for drug checking applications. Sisco E; Nestadt DF; Bloom MB; Schneider KE; Elkasabany RA; Rouhani S; Sherman SG Drug Test Anal; 2024 Sep; 16(9):942-947. PubMed ID: 38043944 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a Rapid Drug Test Device for Urine Fentanyl Compared to Mass Spectrometry and 2 Urine Fentanyl Assays. Laryea ET; Nichols JH J Appl Lab Med; 2024 Sep; 9(5):1020-1024. PubMed ID: 38869381 [TBL] [Abstract][Full Text] [Related]
18. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. Green TC; Park JN; Gilbert M; McKenzie M; Struth E; Lucas R; Clarke W; Sherman SG Int J Drug Policy; 2020 Mar; 77():102661. PubMed ID: 31951925 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of fentanyl immunoassay test strips for rapid in-situ detection of fentanyl and fentanyl analogs in seized samples and alternative matrices. Norman C; Marland V; McKenzie C; Ménard H; Nic Daéid N Int J Drug Policy; 2023 Aug; 118():104102. PubMed ID: 37343365 [TBL] [Abstract][Full Text] [Related]
20. Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. Peiper NC; Clarke SD; Vincent LB; Ciccarone D; Kral AH; Zibbell JE Int J Drug Policy; 2019 Jan; 63():122-128. PubMed ID: 30292493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]